Citadel Advisors’s Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 RONI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-212,709
Closed -$132K 14591
2022
Q1
$132K Buy
212,709
+205
+0.1% +$194 ﹤0.01% 11997
2021
Q4
$319K Sell
212,504
-10,369
-5% -$16.1K ﹤0.01% 10791
2021
Q3
$357K Buy
+222,873
New +$336K ﹤0.01% 10677

Other funds holding RONI.WS

Citadel Advisors's RONI.WS Position: Q2 2022 in Review

Citadel Advisors sold out of Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (RONI.WS) in Q2 2022, closing a stake of 212,709 shares — an estimated $132K sold.

Citadel Advisors first reported a position in RONI.WS in Q3 2021 and held it in 3 quarters. The position peaked at $357K in Q3 2021. 41 funds tracked by Wall St. Rank hold RONI.WS as of Q2 2022.

  • Citadel Advisors reported no remaining Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 212,709 Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $132K.
  • Citadel Advisors first reported a position in Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 3 quarters.
  • Citadel Advisors's Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $357K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.